Treatment Intensification after Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes-The RESTORE-G Real-World Study

被引：0
|
作者：
Candido, Riccardo
Nicolucci, Antonio
Larosa, Monica
Rossi, Maria Chiara
Napoli, Raffaele
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-87-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study
    Candido, Riccardo
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Napoli, Raffaele
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (11) : 2294 - 2305
  • [2] Intensification of Glucagon-Like Peptide-1 Receptor Agonists Therapy with Glargine 300 U/mL or IDegLira-The RESTORE-G Real-World Study
    Candido, Riccardo
    Nicolucci, Antonio
    Rossi, Maria Chiara
    Larosa, Monica
    Napoli, Raffaele
    DIABETES, 2023, 72
  • [3] Intensification of Glucagon-Like Peptide-1 Receptor Agonists Therapy with First and Second Generation Basal Insulins-The RESTORE-G Real-World Study
    Napoli, Raffaele
    Larosa, Monica
    Nicolucci, Antonio
    Rossi, Maria Chiara
    Candido, Riccardo
    DIABETES, 2023, 72
  • [4] Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study
    Napoli, Raffaele
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Candido, Riccardo
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3576 - 3586
  • [5] Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world
    Franch-Nadal, Josep
    Granado-Casas, Minerva
    Mata-Cases, Manel
    Ortega, Emilio
    Vlacho, Bogdan
    Mauricio, Didac
    PRIMARY CARE DIABETES, 2022, 16 (06) : 810 - 817
  • [6] Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Hansen, K. B.
    Knop, F. K.
    Holst, J. J.
    Vilsboll, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (08) : 1154 - 1160
  • [7] Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study
    Xu, Yunwen
    Boyle, Thomas A.
    Lyu, Beini
    Ballew, Shoshana H.
    Selvin, Elizabeth
    Chang, Alexander R.
    Inker, Lesley A.
    Grams, Morgan E.
    Shin, Jung-Im
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (07) : 1112 - 1121
  • [8] Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
    Edwards, C. M. B.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (04) : 198 - 201
  • [9] Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area
    Mata-Cases, Manel
    Franch-Nadal, Josep
    Ortega, Emilio
    Rear, Jordi
    Gratacos, Monica
    Vlacho, Bogdan
    Mauricio, Didac
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (10) : 1735 - 1744
  • [10] Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States
    Weiss, Tracey
    Carr, Richard D.
    Pal, Sampriti
    Yang, Lingfeng
    Sawhney, Baanie
    Boggs, Robert
    Rajpathak, Swapnil
    Iglay, Kristy
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 2337 - 2345
12345